<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863588</url>
  </required_header>
  <id_info>
    <org_study_id>6433</org_study_id>
    <nct_id>NCT02863588</nct_id>
  </id_info>
  <brief_title>Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis</brief_title>
  <acronym>TREXO</acronym>
  <official_title>Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ocular toxoplasmosis (OT) is a major cause of visual impairment worldwide. OT is responsible
      for 30 to 50% of posterior uveitis. It is characterized by dormant infections that may
      reactivate without known reasons, causing severe irreversible visual loss. The overall
      recurrence rate of OT in Europe is greater than 80% for patients and may range from one
      episode to 11 episodes (1% of OT) in the most extreme cases. Current treatments do not reduce
      the risk of recurrences and the risk of toxoplasmosis recurrence cannot be predicted in these
      immunocompetent patients. These clinical and biological expression changes might be related
      to an individual genetic susceptibility of each patient. The advanced analysis of the entire
      genome now possible to consider the project.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 30, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Highlighting of genetic mutations associated with the susceptibility to Toxoplasma gondii.severe eye recurrences. Mutation analysis will be done by exome sequencing of the subjects included in this study</measure>
    <time_frame>This analysis will be performed on a blood sample taken in patients included in the inclusion visit</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Toxoplasmosis Infection</condition>
  <condition>Genotype II</condition>
  <condition>Ocular Toxoplasmosis With Recurrences</condition>
  <arm_group>
    <arm_group_label>seropositive for Toxoplasma gondii</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>seropositive for Toxoplasma gondii</intervention_name>
    <description>blood sample</description>
    <arm_group_label>seropositive for Toxoplasma gondii</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  seropositive for Toxoplasma gondii (for patient and parents)

          -  Infection with genotype II (for patient and parents)

          -  ocular toxoplasmosis recurrences &gt;5 (patients only)

        Exclusion Criteria:

          -  Parents seronegative for T. gondii infection

          -  Infection with others genotypes than type II
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud SAUER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud SAUER, MD</last_name>
    <phone>03 69 55 13 13</phone>
    <phone_ext>0033</phone_ext>
    <email>arnaud.sauer@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital, Strasbourg, france</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud Sauer, MD</last_name>
      <email>arnaud.sauer@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
    <mesh_term>Toxoplasmosis</mesh_term>
    <mesh_term>Toxoplasmosis, Ocular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

